FindTrial
Sign In

Influence of Surgical Procedure Selection on Survival in <=2 cm Lung Adenocarcinoma with High-Risk Pathological Factors

Influence of Surgical Procedure Selection on Survival in <=2 cm Lung Adenocarcinoma with High-Risk Pathological Factors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115579
Enrollment
Unknown
Registered
2025-12-29
Start date
2026-01-05
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Observation group:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >=18 years; 2.Radiographically confirmed stage T1a–T1b ; 3.Underwent lobectomy, anatomic segmentectomy, or wedge resection; 4.Presence of at least one of the following high-risk pathological features: lymphovascular invasion (+); containing micropapillary, solid, complex glandular, or cribriform patterns; spread through air spaces (STAS) (+); poorly differentiated tumor; pleural invasion (+).

Exclusion criteria

Exclusion criteria: 1.Non-elective surgery; 2.History of prior malignancy; 3.Receipt of neoadjuvant or adjuvant therapy; 4.Missing key pathological data.

Design outcomes

Primary

MeasureTime frame
Disease-free Survival;—

Secondary

MeasureTime frame
Overall Survival;—

Countries

China

Contacts

Public ContactJiandong Mei

West China Hospital, Sichuan University

jiandongmei@aliyun.com+86 189 8060 1762

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026